YD Bio Limited Ordinary Shares

YDES | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.63

-$0.56 (-17.55%)

At close: Sep 21, 2026, 4:00 PM ET

$2.41

-$0.22 (-8.37%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-17.55%

(1D)

Rating

Updated: Aug 22, 2026

18.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $186.29M

1D Range

2.54 3.35

52W Range

1.70 22

Valuation (TTM)

PE -2.66

PB -65.23

EV/EBITDA -60.36

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -0.6%

SBC Adj. FCF Yield -0.6%

SBC Impact N/A

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y 25.4% | 58.5%

Dil EPS 3Y | 5Y -26.5% | -373.2%

FCF 3Y | 5Y -93.2% | -49.6%

Returns

ROA -55.5%

ROE 80.7%

ROIC -8.3%

Financial Health

Net Cash

$6.01M

Current Ratio 5.23

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and c...

Sector Healthcare

Industry Biotechnology

Employees 15

IPO Date Aug 28, 2025

Website www.ydesgroup.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.